With promise to slow aging and cure some types of cancer, a new gene therapy presents cost and access hurdles for CT patients ...

Chantez Sanford Jr., 24, of Southfield, says his life has been transformed after undergoing Lyfgenia gene therapy at Children ...

Scientists at the University College London (UCL) have developed a novel therapy that helps treat patients with T cell acute lymphoblastic leukemia (T-ALL). This form of therapy used genome editing ...

State health officials have a new plan on addressing one of Michigan's most prevalent genetic disorders. Michigan Department ...

Nemours Children's Hospital is now offering Lyfgenia gene therapy. The treatment aims to reduce pain crises and hospital visits for young patients.

It’s a medical breakthrough in treating sickle cell disease and a Michigan man is proof that it works.

Consider the case of patient WB, a 79-year-old male with recurrent diffuse large B cell lymphoma. He was referred for chimeric antigen receptor T-cell therapy (CAR-T), a recent game-changer for ...

Labroots and the Cell & Gene Therapy planning committee are thrilled to announce the 2nd Annual Cell & Gene Therapy Virtual Event Series, live on October 15, 2025. This free, interactive event brings ...

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from ...

The first-in-human Phase-I clinical trial for gene therapy of Hemophilia A has shown clinically significant outcomes.

After the FDA’s first-ever public listening meeting on data-sharing in the cell and gene therapy space, new draft guidance ...